|
| | HB0068 Engrossed | | LRB102 03824 CPF 13838 b |
|
|
1 | | AN ACT concerning regulation.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Hospital Licensing Act is amended by |
5 | | changing Section 10.4 as follows:
|
6 | | (210 ILCS 85/10.4) (from Ch. 111 1/2, par. 151.4)
|
7 | | Sec. 10.4. Medical staff privileges.
|
8 | | (a) Any hospital licensed under this Act or any hospital |
9 | | organized under the
University of Illinois Hospital Act shall, |
10 | | prior to the granting of any medical
staff privileges to an |
11 | | applicant, or renewing a current medical staff member's
|
12 | | privileges, request of the Director of Professional Regulation |
13 | | information
concerning the licensure status , proper |
14 | | credentials, required certificates, and any disciplinary |
15 | | action taken against the
applicant's or medical staff member's |
16 | | license, except: (1) for medical personnel who
enter a |
17 | | hospital to obtain organs and tissues for transplant from a |
18 | | donor in accordance with the Illinois Anatomical Gift Act; or |
19 | | (2) for medical personnel who have been granted disaster |
20 | | privileges pursuant to the procedures and requirements |
21 | | established by rules adopted by the Department. Any hospital |
22 | | and any employees of the hospital or others involved in |
23 | | granting privileges who, in good faith, grant disaster |
|
| | HB0068 Engrossed | - 2 - | LRB102 03824 CPF 13838 b |
|
|
1 | | privileges pursuant to this Section to respond to an emergency |
2 | | shall not, as a result of their acts or omissions, be liable |
3 | | for civil damages for granting or denying disaster privileges |
4 | | except in the event of willful and wanton misconduct, as that |
5 | | term is defined in Section 10.2 of this Act. Individuals |
6 | | granted privileges who provide care in an emergency situation, |
7 | | in good faith and without direct compensation, shall not, as a |
8 | | result of their acts or omissions, except for acts or |
9 | | omissions involving willful and wanton misconduct, as that |
10 | | term is defined in Section 10.2 of this Act, on the part of the |
11 | | person, be liable for civil damages. The Director of
|
12 | | Professional Regulation shall transmit, in writing and in a |
13 | | timely fashion,
such information regarding the license of the |
14 | | applicant or the medical staff
member, including the record of |
15 | | imposition of any periods of
supervision or monitoring as a |
16 | | result of alcohol or
substance abuse, as provided by Section |
17 | | 23 of the Medical
Practice Act of 1987, and such information as |
18 | | may have been
submitted to the Department indicating that the |
19 | | application
or medical staff member has been denied, or has |
20 | | surrendered,
medical staff privileges at a hospital licensed |
21 | | under this
Act, or any equivalent facility in another state or
|
22 | | territory of the United States. The Director of Professional |
23 | | Regulation
shall define by rule the period for timely response |
24 | | to such requests.
|
25 | | No transmittal of information by the Director of |
26 | | Professional Regulation,
under this Section shall be to other |
|
| | HB0068 Engrossed | - 3 - | LRB102 03824 CPF 13838 b |
|
|
1 | | than the president, chief
operating officer, chief |
2 | | administrative officer, or chief of
the medical staff of a |
3 | | hospital licensed under this Act, a
hospital organized under |
4 | | the University of Illinois Hospital Act, or a hospital
|
5 | | operated by the United States, or any of its |
6 | | instrumentalities. The
information so transmitted shall be |
7 | | afforded the same status
as is information concerning medical |
8 | | studies by Part 21 of Article VIII of the
Code of Civil |
9 | | Procedure, as now or hereafter amended.
|
10 | | (b) All hospitals licensed under this Act, except county |
11 | | hospitals as
defined in subsection (c) of Section 15-1 of the |
12 | | Illinois Public Aid Code,
shall comply with, and the medical |
13 | | staff bylaws of these hospitals shall
include rules consistent |
14 | | with, the provisions of this Section in granting,
limiting, |
15 | | renewing, or denying medical staff membership and
clinical |
16 | | staff privileges. Hospitals that require medical staff members |
17 | | to
possess
faculty status with a specific institution of |
18 | | higher education are not required
to comply with subsection |
19 | | (1) below when the physician does not possess faculty
status.
|
20 | | (1) Minimum procedures for
pre-applicants and |
21 | | applicants for medical staff
membership shall include the |
22 | | following:
|
23 | | (A) Written procedures relating to the acceptance |
24 | | and processing of
pre-applicants or applicants for |
25 | | medical staff membership, which should be
contained in
|
26 | | medical staff bylaws.
|
|
| | HB0068 Engrossed | - 4 - | LRB102 03824 CPF 13838 b |
|
|
1 | | (B) Written procedures to be followed in |
2 | | determining
a pre-applicant's or
an applicant's
|
3 | | qualifications for being granted medical staff |
4 | | membership and privileges.
|
5 | | (C) Written criteria to be followed in evaluating
|
6 | | a pre-applicant's or
an applicant's
qualifications.
|
7 | | (D) An evaluation of
a pre-applicant's or
an |
8 | | applicant's current health status and current
license |
9 | | status in Illinois.
|
10 | | (E) A written response to each
pre-applicant or
|
11 | | applicant that explains the reason or
reasons for any |
12 | | adverse decision (including all reasons based in whole |
13 | | or
in part on the applicant's medical qualifications |
14 | | or any other basis,
including economic factors).
|
15 | | (2) Minimum procedures with respect to medical staff |
16 | | and clinical
privilege determinations concerning current |
17 | | members of the medical staff shall
include the following:
|
18 | | (A) A written notice of an adverse decision.
|
19 | | (B) An explanation of the reasons for an adverse |
20 | | decision including all
reasons based on the quality of |
21 | | medical care or any other basis, including
economic |
22 | | factors.
|
23 | | (C) A statement of the medical staff member's |
24 | | right to request a fair
hearing on the adverse |
25 | | decision before a hearing panel whose membership is
|
26 | | mutually agreed upon by the medical staff and the |
|
| | HB0068 Engrossed | - 5 - | LRB102 03824 CPF 13838 b |
|
|
1 | | hospital governing board. The
hearing panel shall have |
2 | | independent authority to recommend action to the
|
3 | | hospital governing board. Upon the request of the |
4 | | medical staff member or the
hospital governing board, |
5 | | the hearing panel shall make findings concerning the
|
6 | | nature of each basis for any adverse decision |
7 | | recommended to and accepted by
the hospital governing |
8 | | board.
|
9 | | (i) Nothing in this subparagraph (C) limits a |
10 | | hospital's or medical
staff's right to summarily |
11 | | suspend, without a prior hearing, a person's |
12 | | medical
staff membership or clinical privileges if |
13 | | the continuation of practice of a
medical staff |
14 | | member constitutes an immediate danger to the |
15 | | public, including
patients, visitors, and hospital |
16 | | employees and staff. In the event that a hospital |
17 | | or the medical staff imposes a summary suspension, |
18 | | the Medical Executive Committee, or other |
19 | | comparable governance committee of the medical |
20 | | staff as specified in the bylaws, must meet as |
21 | | soon as is reasonably possible to review the |
22 | | suspension and to recommend whether it should be |
23 | | affirmed, lifted, expunged, or modified if the |
24 | | suspended physician requests such review. A |
25 | | summary suspension may not be implemented unless |
26 | | there is actual documentation or other reliable |
|
| | HB0068 Engrossed | - 6 - | LRB102 03824 CPF 13838 b |
|
|
1 | | information that an immediate danger exists. This |
2 | | documentation or information must be available at |
3 | | the time the summary suspension decision is made |
4 | | and when the decision is reviewed by the Medical |
5 | | Executive Committee. If the Medical Executive |
6 | | Committee recommends that the summary suspension |
7 | | should be lifted, expunged, or modified, this |
8 | | recommendation must be reviewed and considered by |
9 | | the hospital governing board, or a committee of |
10 | | the board, on an expedited basis. Nothing in this |
11 | | subparagraph (C) shall affect the requirement that |
12 | | any requested hearing must be commenced within 15 |
13 | | days after the summary suspension and completed |
14 | | without delay unless otherwise agreed to by the |
15 | | parties. A fair hearing shall be
commenced within |
16 | | 15 days after the suspension and completed without |
17 | | delay, except that when the medical staff member's |
18 | | license to practice has been suspended or revoked |
19 | | by the State's licensing authority, no hearing |
20 | | shall be necessary.
|
21 | | (ii) Nothing in this subparagraph (C) limits a |
22 | | medical staff's right
to permit, in the medical |
23 | | staff bylaws, summary suspension of membership or
|
24 | | clinical privileges in designated administrative |
25 | | circumstances as specifically
approved by the |
26 | | medical staff. This bylaw provision must |
|
| | HB0068 Engrossed | - 7 - | LRB102 03824 CPF 13838 b |
|
|
1 | | specifically describe
both the administrative |
2 | | circumstance that can result in a summary |
3 | | suspension
and the length of the summary |
4 | | suspension. The opportunity for a fair hearing is
|
5 | | required for any administrative summary |
6 | | suspension. Any requested hearing must
be |
7 | | commenced within 15 days after the summary |
8 | | suspension and completed without
delay. Adverse |
9 | | decisions other than suspension or other |
10 | | restrictions on the
treatment or admission of |
11 | | patients may be imposed summarily and without a
|
12 | | hearing under designated administrative |
13 | | circumstances as specifically provided
for in the |
14 | | medical staff bylaws as approved by the medical |
15 | | staff.
|
16 | | (iii) If a hospital exercises its option to |
17 | | enter into an exclusive
contract and that contract |
18 | | results in the total or partial termination or
|
19 | | reduction of medical staff membership or clinical |
20 | | privileges of a current
medical staff member, the |
21 | | hospital shall provide the affected medical staff
|
22 | | member 60 days prior notice of the effect on his or |
23 | | her medical staff
membership or privileges. An |
24 | | affected medical staff member desiring a hearing
|
25 | | under subparagraph (C) of this paragraph (2) must |
26 | | request the hearing within 14
days after the date |
|
| | HB0068 Engrossed | - 8 - | LRB102 03824 CPF 13838 b |
|
|
1 | | he or she is so notified. The requested hearing |
2 | | shall be
commenced and completed (with a report |
3 | | and recommendation to the affected
medical staff |
4 | | member, hospital governing board, and medical |
5 | | staff) within 30
days after the date of the |
6 | | medical staff member's request. If agreed upon by
|
7 | | both the medical staff and the hospital governing |
8 | | board, the medical staff
bylaws may provide for |
9 | | longer time periods.
|
10 | | (C-5) All peer review used for the purpose of |
11 | | credentialing, privileging, disciplinary action, or |
12 | | other recommendations affecting medical staff |
13 | | membership or exercise of clinical privileges, whether |
14 | | relying in whole or in part on internal or external |
15 | | reviews, shall be conducted in accordance with the |
16 | | medical staff bylaws and applicable rules, |
17 | | regulations, or policies of the medical staff. If |
18 | | external review is obtained, any adverse report |
19 | | utilized shall be in writing and shall be made part of |
20 | | the internal peer review process under the bylaws. The |
21 | | report shall also be shared with a medical staff peer |
22 | | review committee and the individual under review. If |
23 | | the medical staff peer review committee or the |
24 | | individual under review prepares a written response to |
25 | | the report of the external peer review within 30 days |
26 | | after receiving such report, the governing board shall |
|
| | HB0068 Engrossed | - 9 - | LRB102 03824 CPF 13838 b |
|
|
1 | | consider the response prior to the implementation of |
2 | | any final actions by the governing board which may |
3 | | affect the individual's medical staff membership or |
4 | | clinical privileges. Any peer review that involves |
5 | | willful or wanton misconduct shall be subject to civil |
6 | | damages as provided for under Section 10.2 of this |
7 | | Act.
|
8 | | (D) A statement of the member's right to inspect |
9 | | all pertinent
information in the hospital's possession |
10 | | with respect to the decision.
|
11 | | (E) A statement of the member's right to present |
12 | | witnesses and other
evidence at the hearing on the |
13 | | decision.
|
14 | | (E-5) The right to be represented by a personal |
15 | | attorney.
|
16 | | (F) A written notice and written explanation of |
17 | | the decision resulting
from the hearing.
|
18 | | (F-5) A written notice of a final adverse decision |
19 | | by a hospital
governing board.
|
20 | | (G) Notice given 15 days before implementation of |
21 | | an adverse medical
staff membership or clinical |
22 | | privileges decision based substantially on
economic |
23 | | factors. This notice shall be given after the medical |
24 | | staff member
exhausts all applicable procedures under |
25 | | this Section, including item (iii) of
subparagraph (C) |
26 | | of this paragraph (2), and under the medical staff |
|
| | HB0068 Engrossed | - 10 - | LRB102 03824 CPF 13838 b |
|
|
1 | | bylaws in
order to allow sufficient time for the |
2 | | orderly provision of patient care.
|
3 | | (H) Nothing in this paragraph (2) of this |
4 | | subsection (b) limits a
medical staff member's right |
5 | | to waive, in writing, the rights provided in
|
6 | | subparagraphs (A) through (G) of this paragraph (2) of |
7 | | this subsection (b) upon
being granted the written |
8 | | exclusive right to provide particular services at a
|
9 | | hospital, either individually or as a member of a |
10 | | group. If an exclusive
contract is signed by a |
11 | | representative of a group of physicians, a waiver
|
12 | | contained in the contract shall apply to all members |
13 | | of the group unless stated
otherwise in the contract.
|
14 | | (3) Every adverse medical staff membership and |
15 | | clinical privilege decision
based substantially on |
16 | | economic factors shall be reported to the Hospital
|
17 | | Licensing Board before the decision takes effect. These |
18 | | reports shall not be
disclosed in any form that reveals |
19 | | the identity of any hospital or physician.
These reports |
20 | | shall be utilized to study the effects that hospital |
21 | | medical
staff membership and clinical privilege decisions |
22 | | based upon economic factors
have on access to care and the |
23 | | availability of physician services. The
Hospital Licensing |
24 | | Board shall submit an initial study to the Governor and |
25 | | the
General Assembly by January 1, 1996, and subsequent |
26 | | reports shall be submitted
periodically thereafter.
|
|
| | HB0068 Engrossed | - 11 - | LRB102 03824 CPF 13838 b |
|
|
1 | | (4) As used in this Section:
|
2 | | "Adverse decision" means a decision reducing, |
3 | | restricting, suspending,
revoking, denying, or not |
4 | | renewing medical staff membership or clinical
privileges.
|
5 | | "Economic factor" means any information or reasons for |
6 | | decisions unrelated
to quality of care or professional |
7 | | competency.
|
8 | | "Pre-applicant" means a physician licensed to practice |
9 | | medicine in all
its
branches who requests an application |
10 | | for medical staff membership or
privileges.
|
11 | | "Privilege" means permission to provide
medical or |
12 | | other patient care services and permission to use hospital
|
13 | | resources, including equipment, facilities and personnel |
14 | | that are necessary to
effectively provide medical or other |
15 | | patient care services. This definition
shall not be |
16 | | construed to
require a hospital to acquire additional |
17 | | equipment, facilities, or personnel to
accommodate the |
18 | | granting of privileges.
|
19 | | (5) Any amendment to medical staff bylaws required |
20 | | because of
this amendatory Act of the 91st General |
21 | | Assembly shall be adopted on or
before July 1, 2001.
|
22 | | (c) All hospitals shall consult with the medical staff |
23 | | prior to closing
membership in the entire or any portion of the |
24 | | medical staff or a department.
If
the hospital closes |
25 | | membership in the medical staff, any portion of the medical
|
26 | | staff, or the department over the objections of the medical |
|
| | HB0068 Engrossed | - 12 - | LRB102 03824 CPF 13838 b |
|
|
1 | | staff, then the
hospital
shall provide a detailed written |
2 | | explanation for the decision to the medical
staff
10 days |
3 | | prior to the effective date of any closure. No applications |
4 | | need to be
provided when membership in the medical staff or any |
5 | | relevant portion of the
medical staff is closed.
|
6 | | (Source: P.A. 96-445, eff. 8-14-09; 97-1006, eff. 8-17-12.)
|
7 | | Section 10. The Hospital Report Card Act is amended by |
8 | | changing Section 25 as follows:
|
9 | | (210 ILCS 86/25)
|
10 | | Sec. 25. Hospital reports.
|
11 | | (a) Individual hospitals shall prepare a quarterly report |
12 | | including all of
the
following:
|
13 | | (1) Nursing hours per patient day, average daily |
14 | | census, and average daily
hours worked
for each clinical |
15 | | service area.
|
16 | | (2) Infection-related measures for the facility for |
17 | | the specific clinical
procedures
and devices determined by |
18 | | the Department by rule under 2 or more of the following |
19 | | categories:
|
20 | | (A) Surgical procedure outcome measures. |
21 | | (B) Surgical procedure infection control process |
22 | | measures.
|
23 | | (C)
Outcome or process measures related to |
24 | | ventilator-associated pneumonia.
|
|
| | HB0068 Engrossed | - 13 - | LRB102 03824 CPF 13838 b |
|
|
1 | | (D) Central vascular catheter-related bloodstream |
2 | | infection rates in designated critical care units.
|
3 | | (3) Information required under paragraph (4) of |
4 | | Section 2310-312 of the Department of Public Health Powers |
5 | | and Duties Law of the
Civil Administrative Code of |
6 | | Illinois.
|
7 | | (4) Additional infection measures mandated by the |
8 | | Centers for Medicare and Medicaid Services that are |
9 | | reported by hospitals to the Centers for Disease Control |
10 | | and Prevention's National Healthcare Safety Network |
11 | | surveillance system, or its successor, and deemed relevant |
12 | | to patient safety by the Department. |
13 | | (5) Each instance of preterm birth and infant |
14 | | mortality within the reporting period, including the |
15 | | racial and ethnic information of the mothers of those |
16 | | infants. |
17 | | (6) Each instance of maternal mortality within the |
18 | | reporting period, including the racial and ethnic |
19 | | information of those mothers. |
20 | | (7) The number of female patients who have died within |
21 | | the reporting period. |
22 | | (8) The number of female patients admitted to the |
23 | | hospital with a diagnosis of COVID-19 and at least one |
24 | | known underlying condition identified by the United States |
25 | | Centers for Disease Control and Prevention as a condition |
26 | | that increases the risk of mortality from COVID-19 who |
|
| | HB0068 Engrossed | - 14 - | LRB102 03824 CPF 13838 b |
|
|
1 | | subsequently died at the hospital within the reporting |
2 | | period. |
3 | | The infection-related measures developed by the Department |
4 | | shall be based upon measures and methods developed by the |
5 | | Centers for Disease Control and Prevention, the Centers for |
6 | | Medicare and Medicaid Services, the Agency for Healthcare |
7 | | Research and Quality, the Joint Commission on Accreditation of |
8 | | Healthcare Organizations, or the National Quality Forum. The |
9 | | Department may align the infection-related measures with the |
10 | | measures and methods developed by the Centers for Disease |
11 | | Control and Prevention, the Centers for Medicare and Medicaid |
12 | | Services, the Agency for Healthcare Research and Quality, the |
13 | | Joint Commission on Accreditation of Healthcare Organizations, |
14 | | and the National Quality Forum by adding reporting measures |
15 | | based on national health care strategies and measures deemed |
16 | | scientifically reliable and valid for public reporting. The |
17 | | Department shall receive approval from the State Board of |
18 | | Health to retire measures deemed no longer scientifically |
19 | | valid or valuable for informing quality improvement or |
20 | | infection prevention efforts. The Department shall notify the |
21 | | Chairs and Minority Spokespersons of the House Human Services |
22 | | Committee and the Senate Public Health Committee of its intent |
23 | | to have the State Board of Health take action to retire |
24 | | measures no later than 7 business days before the meeting of |
25 | | the State Board of Health. |
26 | | The Department shall include interpretive guidelines for |
|
| | HB0068 Engrossed | - 15 - | LRB102 03824 CPF 13838 b |
|
|
1 | | infection-related indicators and, when available, shall |
2 | | include relevant benchmark information published by national |
3 | | organizations.
|
4 | | The Department shall collect the information reported |
5 | | under paragraphs (5) and (6) and shall use it to illustrate the |
6 | | disparity of those occurrences across different racial and |
7 | | ethnic groups. |
8 | | (b) Individual hospitals shall prepare annual reports |
9 | | including vacancy and
turnover rates
for licensed nurses per |
10 | | clinical service area.
|
11 | | (c) None of the information the Department discloses to |
12 | | the public may be
made
available
in any form or fashion unless |
13 | | the information has been reviewed, adjusted, and
validated
|
14 | | according to the following process:
|
15 | | (1) The Department shall organize an advisory |
16 | | committee, including
representatives
from the Department, |
17 | | public and private hospitals, direct care nursing staff,
|
18 | | physicians,
academic researchers, consumers, health |
19 | | insurance companies, organized labor,
and
organizations |
20 | | representing hospitals and physicians. The advisory |
21 | | committee
must be
meaningfully involved in the development |
22 | | of all aspects of the Department's
methodology
for |
23 | | collecting, analyzing, and disclosing the information |
24 | | collected under this
Act, including
collection methods, |
25 | | formatting, and methods and means for release and
|
26 | | dissemination.
|
|
| | HB0068 Engrossed | - 16 - | LRB102 03824 CPF 13838 b |
|
|
1 | | (2) The entire methodology for collecting and |
2 | | analyzing the data shall be
disclosed
to all
relevant |
3 | | organizations and to all hospitals that are the subject of |
4 | | any
information to be made
available to the public before |
5 | | any public disclosure of such information.
|
6 | | (3) Data collection and analytical methodologies shall |
7 | | be used that meet
accepted
standards of validity and |
8 | | reliability before any information is made available
to |
9 | | the public.
|
10 | | (4) The limitations of the data sources and analytic |
11 | | methodologies used to
develop
comparative hospital |
12 | | information shall be clearly identified and acknowledged,
|
13 | | including but not
limited to the appropriate and |
14 | | inappropriate uses of the data.
|
15 | | (5) To the greatest extent possible, comparative |
16 | | hospital information
initiatives shall
use standard-based |
17 | | norms derived from widely accepted provider-developed
|
18 | | practice
guidelines.
|
19 | | (6) Comparative hospital information and other |
20 | | information that the
Department
has
compiled regarding |
21 | | hospitals shall be shared with the hospitals under review
|
22 | | prior to
public
dissemination of such information and |
23 | | these hospitals have 30 days to make
corrections and
to |
24 | | add helpful explanatory comments about the information |
25 | | before the
publication.
|
26 | | (7) Comparisons among hospitals shall adjust for |
|
| | HB0068 Engrossed | - 17 - | LRB102 03824 CPF 13838 b |
|
|
1 | | patient case mix and
other
relevant
risk factors and |
2 | | control for provider peer groups, when appropriate.
|
3 | | (8) Effective safeguards to protect against the |
4 | | unauthorized use or
disclosure
of
hospital information |
5 | | shall be developed and implemented.
|
6 | | (9) Effective safeguards to protect against the |
7 | | dissemination of
inconsistent,
incomplete, invalid, |
8 | | inaccurate, or subjective hospital data shall be developed
|
9 | | and
implemented.
|
10 | | (10) The quality and accuracy of hospital information |
11 | | reported under this
Act
and its
data collection, analysis, |
12 | | and dissemination methodologies shall be evaluated
|
13 | | regularly.
|
14 | | (11) Only the most basic identifying information from |
15 | | mandatory reports
shall be
used, and
information |
16 | | identifying a patient, employee, or licensed professional
|
17 | | shall not be released.
None of the information the |
18 | | Department discloses to the public under this Act
may be |
19 | | used to
establish a standard of care in a private civil |
20 | | action.
|
21 | | (d) Quarterly reports shall be submitted, in a format set |
22 | | forth in rules
adopted
by the
Department, to the Department by |
23 | | April 30, July 31, October 31, and January 31
each year
for the |
24 | | previous quarter. Data in quarterly reports must cover a |
25 | | period ending
not earlier than
one month prior to submission |
26 | | of the report. Annual reports shall be submitted
by December
|
|
| | HB0068 Engrossed | - 18 - | LRB102 03824 CPF 13838 b |
|
|
1 | | 31 in a format set forth in rules adopted by the Department to |
2 | | the Department.
All reports
shall be made available to the |
3 | | public on-site and through the Department.
|
4 | | (e) If the hospital is a division or subsidiary of another |
5 | | entity that owns
or
operates other
hospitals or related |
6 | | organizations, the annual public disclosure report shall
be |
7 | | for the specific
division or subsidiary and not for the other |
8 | | entity.
|
9 | | (f) The Department shall disclose information under this |
10 | | Section in
accordance with provisions for inspection and |
11 | | copying of public records
required by the Freedom of
|
12 | | Information Act provided that such information satisfies the |
13 | | provisions of
subsection (c) of this Section.
|
14 | | (g) Notwithstanding any other provision of law, under no |
15 | | circumstances shall
the
Department disclose information |
16 | | obtained from a hospital that is confidential
under Part 21
of |
17 | | Article VIII of the Code of Civil Procedure.
|
18 | | (h) No hospital report or Department disclosure may |
19 | | contain information
identifying a patient, employee, or |
20 | | licensed professional.
|
21 | | (Source: P.A. 101-446, eff. 8-23-19.)
|